5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland
- PMID: 20179425
- PMCID: PMC2840230
- DOI: 10.4161/mabs.2.2.11302
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland
Similar articles
-
6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.MAbs. 2011 Mar-Apr;3(2):111-32. doi: 10.4161/mabs.3.2.14788. Epub 2011 Mar 1. MAbs. 2011. PMID: 21441785 Free PMC article.
-
8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.MAbs. 2013 May-Jun;5(3):339-57. doi: 10.4161/mabs.24105. Epub 2013 Mar 14. MAbs. 2013. PMID: 23493119 Free PMC article.
-
4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland.MAbs. 2009 Mar-Apr;1(2):93-103. doi: 10.4161/mabs.1.2.7890. Epub 2009 Mar 20. MAbs. 2009. PMID: 20061813 Free PMC article.
-
Monoclonal antibody therapeutics: history and future.Curr Opin Pharmacol. 2012 Oct;12(5):615-22. doi: 10.1016/j.coph.2012.08.001. Epub 2012 Aug 21. Curr Opin Pharmacol. 2012. PMID: 22920732 Review.
-
Monoclonal antibodies as innovative therapeutics.Curr Pharm Biotechnol. 2008 Dec;9(6):423-30. doi: 10.2174/138920108786786358. Curr Pharm Biotechnol. 2008. PMID: 19075682 Review.
Cited by
-
Strategies for enriching and characterizing proteins with inhibitory properties on the yeast surface.Protein Eng Des Sel. 2023 Jan 21;36:gzac017. doi: 10.1093/protein/gzac017. Protein Eng Des Sel. 2023. PMID: 36648434 Free PMC article.
-
6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.MAbs. 2011 Mar-Apr;3(2):111-32. doi: 10.4161/mabs.3.2.14788. Epub 2011 Mar 1. MAbs. 2011. PMID: 21441785 Free PMC article.
-
Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations.Pharm Res. 2011 Dec;28(12):3128-44. doi: 10.1007/s11095-011-0503-9. Epub 2011 Jun 14. Pharm Res. 2011. PMID: 21671135
-
Strategies and challenges for the next generation of therapeutic antibodies.Nat Rev Immunol. 2010 May;10(5):345-52. doi: 10.1038/nri2747. Nat Rev Immunol. 2010. PMID: 20414207 Review.
-
Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.Pharm Res. 2011 May;28(5):949-61. doi: 10.1007/s11095-011-0414-9. Epub 2011 Mar 25. Pharm Res. 2011. PMID: 21437790
References
-
- Beck A, Wurch T, Corvaïa N. Editorial: Therapeutic Antibodies and derivatives: from the bench to the clinic. Curr Pharma Biotechnol. 2008;9:421–422. - PubMed
-
- Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol. 2008;9:423–430. - PubMed
-
- Beck A, Wagner-Rousset E, Wurch T, Corvaia N. Therapeutic antibodies and related products: choosing the right structure for success. Med Sci. 2009;25:1024–1032. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources